{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:13:26Z","timestamp":1794255206720,"version":"4.9.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Wuhan Clinical Medical Research Project","award":["WX20D20"],"award-info":[{"award-number":["WX20D20"]}]},{"name":"Wuhan Clinical Medical Research Project","award":["WZ20Y04"],"award-info":[{"award-number":["WZ20Y04"]}]},{"name":"Wuhan Clinical Medical Research Project","award":["WX21Z48"],"award-info":[{"award-number":["WX21Z48"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>To investigate the clinical features of thrombotic microangiopathy associated with allogeneic hematopoietic stem cell transplantation in children.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective analysis of continuous clinical data from HSCT received in the Department of Hematology and Oncology of Wuhan Children's Hospital from August 1, 2016 to December 31, 2021.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>During this period, 209 patients received allo-HSCT in our department, 20 (9.6%) of whom developed TA-TMA. TA-TMA was diagnosed at a median of 94 (7\u2013289) days post-HSCT. Eleven (55%) patients had early TA-TMA within 100 days post-HSCT, while the other 9 (45%) patients had TA-TMA thereafter. The most common symptom of TA-TMA was ecchymosis (55%), while the main signs were refractory hypertension (90%) and multi-cavity effusion (35%). Five (25%) patients had central nervous system symptoms (convulsions and lethargy). All 20 patients had progressive thrombocytopenia, with 16 patients receiving transfusion of platelets that was ineffective. Ruptured red blood cells were visible in only two patients with peripheral blood smears. Cyclosporine A or Tacrolimus (CNI) dose was reduced once TA-TMA was diagnosed. Nineteen cases were treated with low-molecular-weight heparin, 17 patients received plasma exchange, and 12 patients were treated with rituximab. TA-TMA-related mortality percentage in this study was 45% (9\/20).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Platelet decline and\/or ineffective transfusion post-HSCT should be considered an early indicator of TA-TMA in pediatric patients. TA-TMA in pediatric patients may occur without evidence of peripheral blood schistocytes. Aggressive treatment is required once diagnosis is confirmed, but the long-term prognosis is poor.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12094-023-03129-1","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T02:02:42Z","timestamp":1679968962000},"page":"2451-2461","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical characteristics of pediatric allogeneic hematopoietic stem cell transplantation-associated thrombotic microangiopathy (TA-TMA): a retrospective single-center analysis"],"prefix":"10.1007","volume":"25","author":[{"given":"Linlin","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1932-9282","authenticated-orcid":false,"given":"Hao","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuofeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,28]]},"reference":[{"key":"3129_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2147\/jbm.S102235","volume":"7","author":"J Rosenthal","year":"2016","unstructured":"Rosenthal J. Hematopoietic cell transplantation-associated thrombotic microangiopathy: a review of pathophysiology, diagnosis, and treatment. J Blood Med. 2016;7:181\u20136. https:\/\/doi.org\/10.2147\/jbm.S102235.","journal-title":"J Blood Med"},{"issue":"6","key":"3129_CR2","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","volume":"118","author":"BL Laskin","year":"2011","unstructured":"Laskin BL, Goebel J, Davies SM, Jodele S. Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood. 2011;118(6):1452\u201362. https:\/\/doi.org\/10.1182\/blood-2011-02-321315.","journal-title":"Blood"},{"key":"3129_CR3","doi-asserted-by":"publisher","unstructured":"[Chinese consensus on the diagnosis and management of transplant-associated thrombotic microangiopathy (2021)]. Zhonghua Xue Ye Xue Za Zhi. Mar 14 2021;42(3):177\u2013184. doi:https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2021.03.001","DOI":"10.3760\/cma.j.issn.0253-2727.2021.03.001"},{"key":"3129_CR4","doi-asserted-by":"publisher","unstructured":"Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. Sep 2017;140(3). doi:https:\/\/doi.org\/10.1542\/peds.2017-1904","DOI":"10.1542\/peds.2017-1904"},{"issue":"5","key":"3129_CR5","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.bbmt.2018.01.009","volume":"24","author":"O Horv\u00e1th","year":"2018","unstructured":"Horv\u00e1th O, K\u00e1llay K, Csuka D, Mez\u0151 B, Sinkovits G, Kassa C, et al. Early increase in complement terminal pathway activation marker sC5b-9 is predictive for the development of thrombotic microangiopathy after Stem Cell Transplantation. Biol Blood Marrow Transplant. 2018;24(5):989\u201396. https:\/\/doi.org\/10.1016\/j.bbmt.2018.01.009.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"3129_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.transci.2021.103123","volume":"60","author":"R Matsui","year":"2021","unstructured":"Matsui R, Hagino T, Tsuno NH, Ohtani H, Azuma F, Matsuhashi M, et al. Does time of CCI measurement affect the evaluation of platelet transfusion effectiveness? Transfus Apher Sci. 2021;60(3):103\u201323. https:\/\/doi.org\/10.1016\/j.transci.2021.103123.","journal-title":"Transfus Apher Sci"},{"issue":"8","key":"3129_CR7","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","volume":"11","author":"VT Ho","year":"2005","unstructured":"Ho VT, Cutler C, Carter S, Martin P, Adams R, Horowitz M, et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005;11(8):571\u20135. https:\/\/doi.org\/10.1016\/j.bbmt.2005.06.001.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"3129_CR8","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1111\/bjh.16457","volume":"189","author":"N Epperla","year":"2020","unstructured":"Epperla N, Li A, Logan B, Fretham C, Chhabra S, Aljurf M, et al. Incidence, risk factors for and outcomes of transplant-associated thrombotic microangiopathy. Br J Haematol. 2020;189(6):1171\u201381. https:\/\/doi.org\/10.1111\/bjh.16457.","journal-title":"Br J Haematol"},{"key":"3129_CR9","doi-asserted-by":"publisher","unstructured":"Heybeli C, Sridharan M, Alkhateeb HB, Villasboas Bisneto JC, Buadi FK, Chen D, et al. Characteristics of late transplant-associated thrombotic microangiopathy in patients who underwent allogeneic hematopoietic stem cell transplantation. Am J Hematol. 2020; doi:https:\/\/doi.org\/10.1002\/ajh.25922","DOI":"10.1002\/ajh.25922"},{"issue":"1","key":"3129_CR10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3324\/haematol.10699","volume":"92","author":"T Ruutu","year":"2007","unstructured":"Ruutu T, Barosi G, Benjamin RJ, Clark RE, George JN, Gratwohl A, et al. Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. Haematologica. 2007;92(1):95\u2013100. https:\/\/doi.org\/10.3324\/haematol.10699.","journal-title":"Haematologica"},{"issue":"8","key":"3129_CR11","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","volume":"90","author":"BS Cho","year":"2010","unstructured":"Cho BS, Yahng SA, Lee SE, Eom KS, Kim YJ, Kim HJ, et al. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation. Transplantation. 2010;90(8):918\u201326. https:\/\/doi.org\/10.1097\/TP.0b013e3181f24e8d.","journal-title":"Transplantation"},{"issue":"4","key":"3129_CR12","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","volume":"124","author":"S Jodele","year":"2014","unstructured":"Jodele S, Davies SM, Lane A, Khoury J, Dandoy C, Goebel J, et al. Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults. Blood. 2014;124(4):645\u201353. https:\/\/doi.org\/10.1182\/blood-2014-03-564997.","journal-title":"Blood"},{"key":"3129_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40164-018-0106-9","volume":"7","author":"E Wirtschafter","year":"2018","unstructured":"Wirtschafter E, VanBeek C, Linhares Y. Bone marrow transplant-associated thrombotic microangiopathy without peripheral blood schistocytes: a case report and review of the literature. Exp Hematol Oncol. 2018;7:14. https:\/\/doi.org\/10.1186\/s40164-018-0106-9.","journal-title":"Exp Hematol Oncol"},{"key":"3129_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3389\/fped.2019.00133","volume":"7","author":"CC Dvorak","year":"2019","unstructured":"Dvorak CC, Higham C, Shimano KA. Transplant-associated thrombotic microangiopathy in pediatric hematopoietic cell transplant recipients: a practical approach to diagnosis and management. Front Pediatr. 2019;7:133. https:\/\/doi.org\/10.3389\/fped.2019.00133.","journal-title":"Front Pediatr"},{"issue":"8","key":"3129_CR15","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1038\/s41409-021-01283-0","volume":"56","author":"JA Young","year":"2021","unstructured":"Young JA, Pallas CR, Knovich MA. Transplant-associated thrombotic microangiopathy: theoretical considerations and a practical approach to an unrefined diagnosis. Bone Marrow Transplant. 2021;56(8):1805\u201317. https:\/\/doi.org\/10.1038\/s41409-021-01283-0.","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"3129_CR16","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1007\/s00467-017-3803-4","volume":"33","author":"EG Seaby","year":"2018","unstructured":"Seaby EG, Gilbert RD. Thrombotic microangiopathy following haematopoietic stem cell transplant. Pediatr Nephrol. 2018;33(9):1489\u2013500. https:\/\/doi.org\/10.1007\/s00467-017-3803-4.","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"3129_CR17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/jca.21352","volume":"30","author":"S Mulay","year":"2015","unstructured":"Mulay S, Kreuter JD, Bryant SC, Elliott MA, Hogan WJ, Winters JL, et al. Outcomes of plasma exchange in patients with transplant-associated thrombotic microangiopathy based on time of presentation since transplant. J Clin Apher. 2015;30(3):147\u201353. https:\/\/doi.org\/10.1002\/jca.21352.","journal-title":"J Clin Apher"},{"issue":"3","key":"3129_CR18","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/j.1537-2995.2012.03776.x","volume":"53","author":"S Jodele","year":"2013","unstructured":"Jodele S, Laskin BL, Goebel J, Khoury JC, Pinkard SL, Carey PM, et al. Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy? Transfusion. 2013;53(3):661\u20137. https:\/\/doi.org\/10.1111\/j.1537-2995.2012.03776.x.","journal-title":"Transfusion"},{"issue":"4","key":"3129_CR19","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41409-022-01581-1","volume":"57","author":"LP Yang","year":"2022","unstructured":"Yang LP, Zhao P, Wu YJ, Fu HX, He Y, Mo XD, et al. Treatment outcome and efficacy of therapeutic plasma exchange for transplant-associated thrombotic microangiopathy in a large real-world cohort study. Bone Marrow Transplant. 2022;57(4):554\u201361. https:\/\/doi.org\/10.1038\/s41409-022-01581-1.","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"3129_CR20","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1161\/circresaha.120.317447","volume":"127","author":"JD McFadyen","year":"2020","unstructured":"McFadyen JD, Stevens H, Peter K. The emerging threat of (Micro)Ttrombosis in COVID-19 and its therapeutic implications. Circ Res. 2020;127(4):571\u201387. https:\/\/doi.org\/10.1161\/circresaha.120.317447.","journal-title":"Circ Res"},{"issue":"2","key":"3129_CR21","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/trf.12859","volume":"55","author":"SS Kim","year":"2015","unstructured":"Kim SS, Patel M, Yum K, Keyzner A. Hematopoietic stem cell transplant-associated thrombotic microangiopathy: review of pharmacologic treatment options. Transfusion. 2015;55(2):452\u20138. https:\/\/doi.org\/10.1111\/trf.12859.","journal-title":"Transfusion"},{"key":"3129_CR22","doi-asserted-by":"publisher","unstructured":"Higham CS, Shimano KA, Melton A, Kharbanda S, Chu J, Dara J, et al. A pilot trial of prophylactic defibrotide to prevent serious thrombotic microangiopathy in high-risk pediatric patients. Pediatr Blood Cancer. 2022;69(5):e29641. doi:https:\/\/doi.org\/10.1002\/pbc.29641","DOI":"10.1002\/pbc.29641"},{"issue":"13","key":"3129_CR23","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1182\/blood.2019004218","volume":"135","author":"S Jodele","year":"2020","unstructured":"Jodele S, Dandoy C, Lane A, Laskin B, Teusink-Cross A, Myers K, et al. Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab. Blood. 2020;135(13):1049\u201357. https:\/\/doi.org\/10.1182\/blood.2019004218.","journal-title":"Blood"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-023-03129-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-023-03129-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-023-03129-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T19:28:21Z","timestamp":1687807701000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-023-03129-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,28]]},"references-count":23,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["3129"],"URL":"https:\/\/doi.org\/10.1007\/s12094-023-03129-1","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,28]]},"assertion":[{"value":"7 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Ethics Committee of Wuhan Children's Hospital (2022R017-E01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was done after agreement from the local ethics committee and written informed consent was obtained from all participants and\/or their guardians.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent statement"}}]}}